About this trial
A proof of concept case study to investigate accelerated LIFU protocol in chronic pain and anxiety populations.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
GAD Symptoms - GAD-7 score >= 10, OASIS score >= 8, or PSWQ score >= 45. OR Chronic pain symptoms - moderate to severe pain, present for at least 3 months.
Disqualifiers
Claustrophobia
Contraindications to MRI or CT
Active medical disorder with CNS effects
History of neurologic disorder
Trial design
Single group
Treatments tested in this trial
Low Intensity Focused Ultrasound
DeviceLow-Intensity Focused Ultrasound applied multiple times in a single study visit.
Treatment groups
Trial outcomes
Primary outcomes
Safety - monitoring of possible symptoms
Symptom monitoring before and after LIFU applications and throughout 6 months of follow-up. Each symptom is presented with a likert scale (absent, mild, moderate, severe) - along with a free response option for any symptoms not included in the list.
Changes in Chronic Pain - self report
Participants will complete the Brief Pain Inventory (BPI) at multiple time points throughout the 6 month period. This questionnaire asks participants to rate their pain on a 10 point scale (10 being the most pain).
Changes in Anxiety - self report
Participants will complete the Beck Anxiety Inventory (BAI) at multiple time points before and after LIFU application to track changes in anxiety throughout the 6 month timeframe. The BAI probes different symptoms of anxiety and participants rate it on a likert scale (not at all, mildly, moderately, or severely).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: